Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators

Christopher B Weldon1, Steven Elliott, Yun Zhu

  • 1Department of Surgery, Tulane Cancer Center, New Orleans, LA 70112, USA.

Surgery
|August 10, 2004
PubMed
Abstract

Insights

Estrogen receptor coactivators NCOA-1 and NCOA-3 promote breast cancer cell survival. Inhibiting these coactivator proteins enhances TNF-alpha-induced cell death, suggesting a therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Endocrinology

Background:

  • Estrogen receptor (ER) activity relies on coactivator (CoA) proteins.
  • The specific role of CoA-ER interactions in breast cancer apoptosis is not well understood.

Purpose of the Study:

  • To investigate the role of p160 coactivator family members (NCOA-1, NCOA-2, NCOA-3) in estrogen signaling and breast cancer cell survival.
  • To explore the potential of inhibiting coactivator function as a therapeutic strategy.

Main Methods:

  • Transient transfection of MCF-7 cells with expression vectors for NCOA-1, NCOA-2, or NCOA-3.
  • Assessing cell survival using viability and clonogenic assays.
  • Evaluating estrogen signaling via an estrogen response element (ERE)-luciferase reporter assay.
  • Utilizing dominant-inhibitory (DI)-decoy coactivator constructs to inhibit coactivator function.

Main Results:

  • Overexpression of NCOA-1, NCOA-2, and NCOA-3 significantly enhanced estrogen-mediated gene expression.
  • NCOA-1, NCOA-2, and NCOA-3 overexpression suppressed tumor necrosis factor alpha (TNF-alpha)-induced cell death, promoting cell survival.
  • NCOA-1-mediated survival was confirmed to involve suppression of TNF-alpha-induced apoptosis.
  • DI-decoy-NCOA-1 and DI-decoy-NCOA-3 significantly suppressed clonogenic survival and estrogen-stimulated colony formation, while DI-decoy-NCOA-2 had no significant effect.

Conclusions:

  • NCOA-1 and NCOA-3 overexpression exhibit potent survival effects in breast carcinoma cells.
  • Dominant-inhibitory coactivator constructs increased TNF-alpha-induced cell death and blocked estrogen-induced survival.
  • Inhibiting coactivator proteins presents a viable mechanism for increasing breast cancer sensitivity to therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...